期刊論文| 1. | Gaviria, Mario、Kilic, Burcu(20210512)。A Network Analysis of COVID-19 mRNA Vaccine Patents。Nature Biotechnology，39(5)，546-548。   |
| 2. | 陳家駿(20210800)。新冠疫情下藥物及疫苗之可專利性與相關侵權爭訟初探。月旦醫事法報告，58，126-146。 延伸查詢 |
| 3. | 陳家駿(20210700)。新冠疫情下藥物及疫苗之可專利性與相關侵權爭訟初探。月旦醫事法報告，57，135-152。 延伸查詢 |
| 4. | 施雅薰(20200500)。COVID-19疫情下的專利議題--從瑞德西韋與美國Labrador Diagnostics LLC v. BioFire Diagnostics案件論起。科技法律透析，32(5)，2-12。 延伸查詢 |
| 5. | 陳家駿(20210700)。COVID-19疫苗專利與全球公共衛生人道衝突下之衡平協調機制探析。月旦法學，314，63-84。 延伸查詢 |
| 6. | Jean, Patrice P.、Russo, Lynn(20210311)。IP and COVID-19: Disputes Over mRNA-related Patents are Poised to Persist。Pharmaceutical Executive，41(3)，20-21。 |
| 7. | (20200904)。Moderna Loses Key Patent Challenge。Nature Biotechnology，38(9)。 |
| 8. | Bonadio, Enrico、Baldini, Andrea(2020)。COVID-19, Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health。European Journal of Risk Regulation，11(2)，390-395。 |
| 9. | 楊莉、李野、楊立夫(2007)。藥品專利保護的Bolar例外研究。中國新藥雜誌，16(15)，1145-1148。 延伸查詢 |
| 10. | (20201213)。Allele alleges unlicensed use of its mNeonGreen by Pfizer, BioNTech & Regeneron。Focus on Pigments，2020(11/12)，7。 |
其他| 1. | Jin, Regina(20200403)。Potential Coronavirus Drug: Patent Rights Amid Global Pandemic，http://www.fordhamiplj.org/2020/04/03/potential-coronavirus-drug-patent-rights-amid-global-pandemic/。 |
| 2. | Lowe, Derek(20200724)。Formulating RNA: And Owning It，https://blogs.sciencemag.org/pipeline/archives/2020/07/24/formulating-rna-and-owning-it。 |
| 3. | Shores, Dan(20201111)。Breaking Down Moderna's COVID-19 Patent Pledge: Why Did They Do It?，https://ipwatchdog.com/2020/11/11/breaking-modernas-COVID-19-patent-pledge/id=127224/。 |
| 4. | COVID-19 Vaccine Tracker Team。Approved Vaccines，https://covid19.trackvaccines.org/vaccines/approved/。 |
| 5. | Plieth, Jacob(20200724)。The Covid-19 Vaccine Battle Just Got Interesting，https://www.evaluate.com/vantage/articles/news/patents-and-litigation/covid-19-vaccine-battle-just-got-interesting。 |
| 6. | Shores, Daniel(20201116)。COVID-19 Vaccine Leader Moderna "Not Aware of Any Significant Intellectual Property Impediments" in Development of its Vaccine Despite Mixed Results at PTAB，https://www.jdsupra.com/legalnews/covid-19-vaccine-leader-moderna-not-81369/。 |
| 7. | Wolfe, Jan(20200724)。Moderna loses challenge to Arbutus patent on vaccine technology，https://www.reuters.com/article/us-moderna-patent-idUSKCN24O2XY。 |
| 8. | Gilead Sciences Inc(20180731)。治療沙粒病毒科和冠狀病毒科病毒感染的方法(CN108348526A)。，https://patentimages.storage.googleapis.com/4b/16/8b/41358e7d1362f8/CN108348526A.pdf。 延伸查詢 |
| 9. | Philippidis, Alex(20200212)。Coronavirus: China's BrightGene Manufactures APIs of Gilead's Remdesivir，https://www.genengnews.com/news/coronavirus-chinas-brightgene-manufactures-apis-of-gileads-remdesivir/。 |
| 10. | 肖隆平(20200214)。有風險，博瑞醫藥為何還要仿製瑞德西韋？，https://www.bjnews.com.cn/detail/158166433815020.html。 延伸查詢 |
| 11. | 張新鋒(2008)。專利權的例外之適用：評伊萊利利公司訴甘李藥業有限公司案，http://old.civillaw.com.cn/article/default.asp?id=55042&_d_id=ed851dd3ac887870c209117344f3e3。 延伸查詢 |
| 12. | Tapscott, Rebecca(20201007)。Regeneron, Pfizer and BioNTech Accused of Infringing Allele Patent in Connection with COVID-19 Technologies，https://ipwatchdog.com/2020/10/07/regeneron-pfizer-biontech-accused-infringing-allele-patent-connection-covid-19-technologies/id=126017/。 |
| 13. | Liu, Angus(20201006)。Pfizer-BioNTech, Regeneron sued for patent infringement with COVID-19 products，https://www.fiercepharma.com/pharma/pfizer-biontech-regeneron-sued-for-infringement-allele-s-patent-their-covid-19-products。 |
| 14. | Evall, Joseph，Mark, Richard，First, Amanda(20200702)。Don't Count On PREP Act to Defend Pandemic IP Infringement，https://www.law360.com/articles/1287376。 |
| 15. | Kashyap, Aruna，Wurth, Margaret(20201116)。Waiving Intellectual Property Rules Key to Beating Covid-19，https://www.hrw.org/news/2020/11/16/waiving-intellectual-property-rules-key-beating-covid-19。 |
| 16. | Hughes, Justin(20210506)。Biden Decision on COVID Vaccine Patent Waivers Is More about Global Leadership than IP，https://www.usatoday.com/story/opinion/2021/05/06/covid-vaccine-patents-biden-boosts-american-leadership-column/4932766001/。 |